A federal appeals court on Monday rejected Pfizer Inc.’s challenge to a U.S. anti-kickback law that the drugmaker said prevented it from helping heart failure patients, many with low incomes, afford drugs that cost $225,000 a year.
Tag Archive for: Vyndaquel. Vyndamax
An interim analysis of AstraZeneca and partner Ionis Pharmaceuticals’ eplontersen showed the experimental drug met the main goals in a late-stage trial in patients with a rare, fatal disease, the Anglo-Swedish drugmaker said on Tuesday.